[1]
“Frequency of molecular response in a patient of chronic myeloid leukemia taking Tyrosine Kinase Inhibitors after 1 year of treatment Pakistan Institute of Medical Sciences experience”, Med J South Punjab, vol. 6, no. 01, Mar. 2025, doi: 10.61581/.